Advanced search Subscribe

Home > News > Community notices > Opportunity

Systematic Reviewers x2 new positions – Research Division, Cancer Council, NSW

Closing date: 01 November 2016

Job reference: CRD 1016 SR
Location: Sydney, NSW

- Conduct critical systematic reviews for the VISION 2040 research program, which aims to answer the question: what is the best and most effective way to make the greatest impact in beating cancer?
- Unique opportunity to be part of what is to be a highly visible and varied research project, that will have real life impacts
- May suit a recent MPH student with 12 -18 months evidence based research experience looking for an opportunity that offers variety and the potential to expand clinical knowledge and methodological skills and become published.

Based in our Woolloomooloo office, you will join our highly regarded Cancer Research Division (CRD), which provides expert, impartial evidence that influences the actions of Cancer Council NSW, policy makers, practitioners and the community to reduce the national and international impact of cancer.

You will contribute to the new VISION 2040 program, which has an overall objective to determine which cancer control interventions and programs can effectively and cost-effectively reduce the numbers of people dying from cancer.

This will involve obtaining projections of Australian cancer mortality rates, and numbers of cancer deaths, out to the year 2040 and modelling the impacts of different cancer control strategies. The initial project findings will be used to guide the process of policy prioritisation for Cancer Councils to support the efficient and effective use of cancer control programs in the prevention, early detection and treatment of cancer at a population level.
Closing date: 01 November 2016


This Vacancy, fellowship or scholarship also featured in This Week in PHC Issue: 27 October 2016

See also

Related Topic Searches (6)

Search for more using the following Topic Searches:

Learn more and view all Topic Searches.


Search News

Share this content

Share via Twitter Share via LinkedIn Share via Facebook Share via email